Royal Healthcare in Singapore provides NEC’s “FonesVisuas Test” for Disease Risk Prediction
TOKYO, Mar 26, 2026 – (JCN Newswire via SeaPRwire.com) – NEC Corporation (NEC; TSE: 6701) announced that its FonesVisuas Test, an innovative blood test that predicts disease risk, is being offered … Baca lebih lajut
